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Abstract 
DNA gyrase is an essential topoisomerase found in all bacteria. It is encoded by gyrB and gyrA genes. These genes are 
organized differently in different bacteria. Direct comparison of Mycobacterium tuberculosis and Mycobacterium 
smegmatis genomes reveals presence of an additional gyrB i  M. smegmatis flanked by novel genes. Analysis of the 
amino acid sequence of GyrB from different organisms suggests that the orphan GyrB in M. smegmatis may have an 
important cellular role. 
[Jain P. and Nagaraja V. 2002 An orphan gyrB i the Mycobacterium smegmatis genome uncovered by comparative genomics. J . 
Genet. 81, 105–110] 
Introduction 
Topoisomerases are the enzymes that interconvert bet-
ween different topological forms of DNA. On the basis of 
structure and mechanism of reaction, the enzymes are 
broadly classified into type I and type II topoisomerases 
(Liu et al. 1980; Berger t al. 1998). Type I topoisome-
rases cleave only one strand of DNA and change the link-
ing number in steps of one. Type II topoisomerases on 
the other hand cleave both strands of DNA to form a 5¢-
phosphotyrosine linkage, pass another duplex segment of 
DNA through the break, and religate the broken ends 
(Wang 1996). Thus, unlike type I topoisomerases, type II 
topoisomerases change the linking number in steps of 
two (Brown and Cozzarelli 1979; Liu etal. 1980). DNA 
gyrase, topoisomerase IV of bacteria and eukaryotic to-
poisomerase II are typical members of the latter class. All 
type II topoisomerases have the ability to catalyse ATP-
dependent catenation/decatenation and knotting/ unkno -
ting of DNA (Cozzarelli 1980; Gellert 1981) and show 
high degree of conservation in their primary sequence 
(Madhusudan and Nagaraja 1996). Among all the topo-
isomerases, bacterial DNA gyrase—a type II enzyme—is 
the only enzyme capable of introducing negative super-
coils into DNA (Wang 1996). 
 DNA gyrase was initially discovered in E. coli in 1976 
(Gellert et al. 1976a). The enzyme from E. coli has been 
subjected to extensive investigation with respect to gene 
organization and regulation, biochemical charaterization, 
reaction mechanism and interaction with various drugs 
(Maxwell and Gellert 1986; Reece and Maxwell 1991; 
Wang 1996; Maxwell 1997; Champoux 2001). However, 
every bacterial genome analysed contains DNA gyrase. 
The enzyme is a heterotetramer, and is encoded by two 
genes, gyrB and gyrA, which encode important functional  
domains in the enzyme. DNA breakage and religation acti-
vity, which is sensitive to the quinolone class of drugs, 
resides in GyrA subunit (Gellert t al. 1977; Sugino et al. 
1977). ATPase activity, which is inhibited by the cou-
marin class of drugs, resides in GyrB, providing essential 
energetics for the reaction cycle (Gellert et al. 1976b). 
Only the holoenzyme comprising two GyrA and two 
GyrB subunits is capable of catalysing the overall super-
coiling reaction (Klevan and Wang 1980; Sugino et al. 
1980). The indispensability of DNA gyrase could be 
demonstrated by the inhibition of cell growth by various 
inhibitors of the enzyme. This has led to intense study to 
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develop novel anti-i fective agents. As a result, the genes 
have been cloned from a large number of organisms. We 
have previously cloned genes for DNA gyrase (yrB and 
gyrA) from Mycobacterium smegmatis and M. tubercu-
losis (Madhusudan et al. 1994; Madhusudan and Naga-
raja 1995) for detailed characterization of the enzyme 
and to develop them as targets for novel compounds. 
DNA gyrase from mycobacteria differs from the E. coli 
enzyme with respect to susceptibility to various classes 
of inhibitors, antibody cross-reactivity, primary structure 
and biochemical characteristics (Chatterji et al. 2000, 
2001; Manjunatha et al. 2000, 2001a,b, 2002). These stu-
dies have led to the classification of DNA gyrase into 
two subgroups within the prokaryotes (Manjunatha et al. 
2000). 
 Four topoisomerases have been characterized from  
E. coli. Topoisomerase I and topoisomerase III are type 
IA enzymes. DNA gyrase and topoisomerase IV are type 
II enzymes. So far, no additional copy of any of the genes 
encoding a topoisomerase has been reported in E. coli. 
Here we report the uncommon presence of an additional 
gyrB in the M. smegmatis genome and examine its origin. 
Further, we describe the heterogeneity in organization of 
the gyr locus in different bacteria. 
Materials and methods 
M. smegmatis genome sequence was queried using WU-
BLAST 2.0 (TIGR server, http://tigrblast.tigr.org/tgi/). 
The sequence was further queried using BLASTp (NCBI 
BLAST 2.0; default options). GyrB sequences were retrie-
ved from the EMBL database. 
 Programs used in the sequence analysis were part of 
the sequence analysis package from the University of 
Wisconsin Genetics Computer Group (UWGCG), version 
9.1. The following programs were used with the default 
settings: Gap for pairwise alignment, ClustalW for multi-
ple sequence alignment, Macaw to determine the regions 
of local similarity and to generate similarity boxes of sta-
tistical significance. 
 Southern blotting was carried out using genomic DNA 
as described earlier (Madhusudan et al. 1994). 
Results and discussion 
Additional gyrB in M. smegmatis 
We have previously cloned and overexpressed gyrA an
gyrB genes from both M. smegmatis (Madhusudan and 
Nagaraja 1995) and M. tuberculosis (Madhusudan et al. 
1994). DNA fragments comprising gyrB or gyrA or both 
from M. tuberculosis were used to probe for homologous 
genes in M. smegmatis and M. tuberculosis. Southern 
analysis of genomic DNA showed additional DNA frag-
ments hybridizing in case of M. smegmatis which cannot 
be accounted for in the restriction map of gyrBA locus 
(figure 1). In contrast, M. tuberculosis DNA blots did not 
show the additional bands (not shown). These results 
suggested the presence of additional DNA sequences or 
genes similar to gyrase genes in M. megmatis which are 
absent in M. tuberculosis. Analysis of genome sequences 
of the two organisms confirmed these observations. In 
the entire 4,411,529-bp genome of M. tuberculosis only 
gyrB, gyrA and topA genes are found (Cole et al. 1998); 
the g nes encoding topoisomerase IV or topoisomerase 
III are absent (Cole et al. 1998). However, sequence 
analysis of the M. smegmatis genome revealed presence 
of a gene for an additional GyrB protein, confirming the 
r sul  of Southern analysis (figure 1). It should be noted 
that only the gyrB-specific probe picked up the additional 
hybridizing fragments (figure 1), which suggests that the 
additional gyrB is located away from the main gyrBA
locus in the genome. The GyrB homologue shows a high 
degree of similarity of amino acid sequence to GyrB 
from M. megmatis (table 1). No corresponding gyrA was 
found next to this additional gyrB sequence unlike in  
the gyrBAoperon of M. smegmatis and M. tuberculosis 
(Unniraman and Nagaraja 1999; Unniraman et al. 2002). 
Further, no additional gyrA was found elsewhere in the 
genome. We therefore refer to the new gyrB homologue 
as ‘orphan’ gyrB and to the product as orphan GyrB. 
 
Figure 1. Southern analysis of M. smegmatis DNA. Left, 
Hybridization of M. smegmatis SN2 genomic DNA with 1.2-kb 
EcoRI–HpaI fragment of pMN13R carrying M. tuberculosis
gyrB gene (Madhusudan et al. 1994). Right, Hybridization of 
M. smegmatis SN2 genomic DNA with 1.0-kb MluI–SmaI frag-
ment of pMN6R carrying M. tuberculosis gyrA gene (Madhu-
sudan et al. 1994). Identical length fragments hybridize to both 
probes in EcoRI, KpnI and StuI digests. Additional hybridiza-
tion signals in KpnI and StuI digests (left panel) are indicated 
by an asterisk. 
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Characteristics of orphan GyrB 
The orphan GyrB sequence was compared with the already 
characterized GyrB of M. smegmatis and M. tuberculosis 
(table 1). The orphan GyrB shows 85.9% and 76.2% 
identity, and 89.9% and 88.5% similarity to M. smegma-
tis and M. tuberculosis GyrB respectively. Moreover, the 
region important for ATPase activity is highly conserved 
between orphan GyrB and canonical GyrB of M. smeg-
matis. Orphan GyrB sequence was then compared with 
the GyrB sequences of other bacteria. The similarity 
ranged from 40% to 70%, indicating that orphan gyrB is 
a close allele of authentic gyrB. These results imply  
that orphan gyrB is likely to have originated from the 
authentic gyrB of M. smegmatis and not transferred from 
a foreign genome. However, analysis of the primary  
sequence of orphan GyrB reveals deletion of a 30-amino-
acid stretch corresponding to residues 219–248 of M. 
smegmatis GyrB, raising the possibility that the gene is 
vestigial (figure 2a). Pairwise alignment was carried out 
to determine presence or absence of this 30-amino-acid 
stretch in GyrB of various organisms. To represent the 
regions of local similarity and to generate similarity boxes 
of statistical significance Macaw alignment was carried 
out (figure 2b). The additional 30 amino acids found in 
M. smegmatis GyrB are absent in GyrB of many other 
Gram-positive and Gram-negative bacteria, including 
E. coli, indicating that this region is likely to be dispen-
sable for GyrB activity (figure 2b). However, this stretch 
is present in the GyrB of all mycobacterial genomes  
sequenced so far, and deletion of fewer amino acids is 
seen in Streptomyces sphaeroides and S. coelicolor GyrB 
sequences. The presence of an additional 30 amino acids 
in GyrB of some bacteria raises the possibility that this 
region may have a role in species-specific function (see 
later section). The overall similarity of orphan GyrB with 
authentic GyrB from other bacteria suggests that the  
orphan gene is a functional allele in M. smegmatis. 
Organization of gyr locus and location of orphan gyrB 
Organization of the gyr locus shows considerable diversity 
in different bacteria. In E. coli gyrB is located at 83min 
on the circular genome, close to the origin of replication, 
oriC (Bachmann and Low 1980). Although in most orga-
nisms gyrB is found in close proximity to the origin, the 
location of gyrA varies from organism to organism.  
E. coli gyrA is located far away from the origin at 48 min 
(Bachmann and Low 1980). In contrast to all the other 
known systems, in M. smegmatis and M. tuberculosis 
gyrB and gyrA are organized in theform of an operon 
(Unniraman and Nagaraja 1999; Unniraman et al. 2002). 
The presence of an orphan gyrB in M. smegmatis prom-
pted us to look for its location in the genome and organi-
zation of gyrB and gyrA genes in different mycoba terial 
species (figure 3). It is possible that the orphan gyrB and 
the flanking regions arose by partial genome duplication 
events, as is the case in M. bovis BCG Pasteur strain 
(figure 3, and Brosch et al. 2000). Alternatively, only the 
gyrB sequence could have been inserted, either by trans-
position or by recombination events. The gene organi-
zation around oriC and the gyr locus in M. bovis, M. 
tuberculosis and M. smegmatis  nearly identical (figure 
3). The duplication event seen in M. bovis BCG Pasteur 
strain does not appear to be a common feature (figure 3). 
The orphan gyrB in M. smegmatis  present at a distinct 
locus flanked by unknown open reading frames. Nucleo-
tide sequences flanking the orphan gyrB do not provide 
any clues regarding its insertion, which suggests it may 
have been an early event. 
 The presence of this additional gyrB with the chara-
cteristics of a functional allele raises many interesting 
questions regarding its physiological role. Although an 
additional gyrB is uncommon in bacteria, there is a 
precedent in S. sphaeroides. The indispensability of DNA 
gyrase for cell survival is exploited in nature by compet-
ing organisms by evolution of inhibitors and poisons. 
Such organisms develop and retain their own defensive 
strategies. S. sphaeroides i  the natural producer of the 
antibiotic novobiocin, which is a potent inhibitor of DNA 
gyrase of all bacteria. This organism protects itself from 
the action of novobiocin by synthesizing both sensitive 
and resistant GyrB proteins, encoded by two genes, gyrBS 
and gyrBR. There is only one gyrA gene in the genome, 
present downstream of gyrBS and cotranscribed with it 
(Thiara and Cundliffe 1993). Production of GyrBR along 
with GyrA permits survival of S. sphaeroides in presence 
of novobiocin over other species which do not have a 
novobiocin-resistant GyrB. It has been shown that certain 
drugs like cisplatin also inhibit E. coli DNA gyrase acti-
vity and preferentially induce gyrB gene expression 
(Neumann et al. 1996). Other inhibitors of gyrase might 
exist, which bind to the GyrB subunit to inhibit GyrA– 
Table 1. Amino acid sequence homology among GyrB sequences by pairwise alignment.         
 M. tuberculosis 
GyrB 
M. smegmatis  
GyrB 
M. smegmatis  
orphan GyrB         
M. tuberculosis GyrB 100   
M. smegmatis GyrB    91.9 100  
M. smegmatis orphan GyrB    88.5    89.9 100         
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Figure 2. Comparison of GyrB sequences. (a) Pairwise alignm nt of the intragenic region between authentic GyrB and 
orphan GyrB of M. smegmatis. Amino acid residues from 180 to 290 are aligned. (b) Schematic representation of multi-
ple sequence alignmet. The program Macaw was used to represent the statistically significant homology in multiple 
sequence alignment. The sequences aligned are from the region of GyrB shown in a. 
 
(b) 
(a) 
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GyrB interaction or inactivate GyrB. To overcome this, 
either production of a resistant GyrB protein or overex-
pression of the gyrB gene is required (as in E. coli when 
treated with cisplatin). One of the gyrBs in M. smegma-
tis—either the authentic one, which is part of the gyrBA 
operon, or the orphan gyrB—could have been retained as 
a survival strategy against an antibiotic of unknown nature. 
Furthermore, the cellular DNA gyrase is a target for pro-
teinaceous poisons encoded by selfish plasmids. For  
example, CcdB encoded by F plasmid binds to GyrA of 
E. coli and arrests the DNA gyrase reaction at the cova-
lent complex stage (Critchlow et al. 1997; Couturier  
et al. 1998). Similarly, microcin B17 encoded by pMccB 
17 binds to GyrB and is an effective poison of E. coli 
DNA gyrase (Vizan et al. 1991). It is noteworthy that 
E. coli has evolved a counterdefensive strategy of produ-
cing GyrI as an antidote to DNA-gyrase-specific proteina-
ceous poisons (Chatterji and Nagaraja 2002). Although 
microcin B17 and CcdB o not inhibit M. smegmatis 
DNA gyrase (Chatterji et al. 2001), other proteinaceous 
poisons may be encoded by mycobacterial plasmids. A 
point to be noted is that M. smegmatis  a free-living 
saprophytic organism with widespread distribution unlike 
M. tuberculosis and hence likely to encounter a variety of 
plasmids, a large number of Streptomyces species, and 
other bacteria. The additional GyrB could be a mecha-
nism to counter toxins or inhibitors encoded by other 
genomes. 
 It is intriguing that different species of mycobacteria 
have varied GyrB components. What is the physiological 
basis for this differential distribution? Considering the 
large difference in the growth rates of M. smegmatis and 
M. tuberculosis t is possible that orphan GyrB could be 
contributing to the higher levels of enzymatic activity 
required during the log phase of M. smegmatis growth in 
culture. Alternatively, it is expressed differentially under 
certain conditions as an immediate requirement for cellu-
lar function. Another point to be noted is that GyrB is 
intrinsically less stable than GyrA in E. coli (Higgins  
et al. 1978) and also in M. smegmatis (unpublished results 
from our laboratory). The orphan GyrB could be com-
pensating for reduced levels of active GyrB in the cell. 
Th fore the presence of this additional gene copy in  
M. smegmatis could be a mechanism for regulated syn-
thesis of GyrB under certain conditions. A detailed char-
acterization of the orphan GyrB would be of great 
importance in revealing its physiological function. 
Conclusions 
The presence of two genes for GyrB in M. smegmatis 
raises interesting possibilities regarding the intracellular 
functions of the two proteins. The authentic GyrB is 
known to be associated with GyrA in a tetrameric holo-
enzyme that carries out the DNA supercoiling reaction 
(Manjunatha etal. 2002). From our comparative analysis 
it appears that orphan gyrB is a functional allele and 
hence retained in the genome at a different location. It is 
possible that mutation in one GyrB may still allow the 
cell to grow as the other GyrB may provide the required 
functions. This suggestion is testable by making knock-
outs of either one of the gyrB alleles to evaluate their 
indispensability.  
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